Skip to content
Center for Reproductive Rights
Center for Reproductive Rights

Primary Menu

  • About
    • Overview
    • The Center’s Impact
    • Center Leadership & Staff
    • Annual Reports
    • Corporate Engagement
    • Diversity, Equity and Inclusion
    • Careers
    • Contact Us
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • Cases Archive
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Global Advocacy
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
  • News
    • Latest News
    • Stories
    • Events
    • Center in the Spotlight
    • Press Releases
    • Statements
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • U.S. Abortion Rights: Resources
    • Maps
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
    • Repro Red Flags: Agency Watch
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Become a Monthly Donor
    • Make a Donor Advised Fund Gift
    • Leave a Legacy Gift
    • Donate Gifts of Stock
    • Give a Gift in Honor
    • Attend an Event
    • Employee Matching Gifts
    • Mail a Check
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn
Donate
icon-hamburger icon-magnifying-glass Donate
icon-magnifying-glass-teal

A Crucial Option

Center for Reproductive Rights - Center for Reproductive Rights - search logo
search Close Close icon
Center for Reproductive Rights -
Menu Close Menu Close icon
Donate

Primary Menu

  • About
    • Overview
    • The Center’s Impact
    • Center Leadership & Staff
    • Annual Reports
    • Corporate Engagement
    • Diversity, Equity and Inclusion
    • Careers
    • Contact Us
  • Work
    • Overview
    • Litigation
    • Legal Policy and Advocacy
    • Resources & Research
    • Recent Case Highlights
    • Landmark Cases
    • Cases Archive
    • World’s Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
  • Issues
    • Overview
    • Abortion
    • Adolescent Sexual and Reproductive Health and Rights
    • Assisted Reproduction
    • Contraception
    • Humanitarian Settings
    • Maternal Health
    • COVID-19
  • Regions
    • Overview
    • Global Advocacy
    • Africa
    • Asia
    • Europe
    • Latin America and the Caribbean
    • United States
  • News
    • Latest News
    • Stories
    • Events
    • Center in the Spotlight
    • Press Releases
    • Statements
    • Press Room
    • Newsletters
  • Resources
    • Resources & Research
    • U.S. Abortion Rights: Resources
    • Maps
    • World Abortion Laws Map
    • After Roe Fell: Abortion Laws by State
    • Repro Red Flags: Agency Watch
  • Act
    • Overview
    • Give
    • Act
    • Learn
  • Donate
    • Become a Monthly Donor
    • Make a Donor Advised Fund Gift
    • Leave a Legacy Gift
    • Donate Gifts of Stock
    • Give a Gift in Honor
    • Attend an Event
    • Employee Matching Gifts
    • Mail a Check
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • LinkedIn

Related Content

Issues:

Abortion, Definitions, Legal Protections, Legal Restrictions

Regions:

United States

Work:

Engaging Policymakers, In the States (USA)

Type:

News, Story

Follow the Center

Donate Now

Join Now

09.28.2015

Engaging Policymakers Abortion United States News

A Crucial Option

Justin Goldberg

Share

  • facebook
  • Twitter
  • linkedin
  • Email id
https://reproductiverights.org/wp-content/uploads/2018/08/Feature_medAb_9.28.jpg
A Crucial Option
Medication abortion is safe, legal, and capable of revolutionizing reproductive health care.

American women have been using legal medication abortion—an early abortion method that involves taking oral medication rather than having a surgical procedure—for a decade and a half.



In fact, one in four women opt for this method if it is available to her. It’s a safe, non-invasive way to end a pregnancy in a setting where a woman may feel most comfortable.



Yet in recent years, as part of a highly coordinated attack on abortion access, some states have been pushing sham laws to limit the use of medication abortion. Just in 2015, 11 states have introduced 20 bills related to medication abortion. Arkansas alone enacted four restrictions on medication abortion.



“It’s ridiculous,” says Kelly Baden, director of state advocacy at the Center for Reproductive Rights. “These are laws passed under false pretenses by politicians—not doctors—who are doing everything in their power to outlaw abortion altogether. Medication abortion is just one of their many targets, and the result is that it has become harder for a woman who has chosen to end her pregnancy to use this safe method. ”



The medication abortion drug mifepristone was approved by the FDA 15 years ago this month. It has been praised for its excellent safety record (over 99 percent) and for expanding the range of reproductive health options for women. Having options for how to end a pregnancy can be a crucial part of giving woman a better sense of control over her experience and for expanding abortion access.



“The potential for medication abortion to help women access early abortion care even in the face of clinic closures and extremely hostile political environments is part of what makes laws limiting its use so outrageous,” says Baden. “Women in rural areas or for whom getting to a clinic is difficult need to have this safe option kept available to them.



Further, we know that for some women, the opportunity to experience a more private, non-invasive procedure is important to the quality of their overall abortion experience.”



Since mifepristone’s U.S. approval, physicians’ real-world experience has determined a regimen preferable to what was initially approved by the FDA. The existing, outdated FDA label requires a higher dose of medication, which may cause more side effects, and a smaller time frame for use than the evidence shows, medication abortion is now considered safe at least up through nine weeks of pregnancy, rather than at seven weeks as initially indicated.



Opponents of legal abortion have set their sights on the promise of medication abortion and are trying to severely limit its use. Some states have passed laws that prohibit providers from using the most up-to-date, evidence-based regimen for medication abortion. Even more have declared that medication abortion must be administered only by a licensed physician, though there is no medical reason that other kinds of advanced-practice clinicians cannot also dispense mifepristone.



Many states have set out to explicitly exclude abortion access from the burgeoning field of telemedicine, cutting off access to medication abortion for rural women who face barriers to getting to a clinic. These attempts to treat medication abortion differently from other kinds of health care for political reasons have not gone unchallenged.



The Center has been active over the last several years fighting a number of these sham restrictions in the courts. This past year, we were successful in blocking Oklahoma and Arizona’s outdated protocol requirements. We are currently challenging an Arizona law that takes the already outrageous restrictions on medication abortion even further by forcing doctors to give misleading information to patients about the possibility of “reversing” medication abortion.



“Each victory obviously has a huge impact because it allows women to continue to have access to this crucial option for care,” notes Baden. “But the wins also have notable policy implications. A law has to do what it says it does, and the courts’ rulings affirm that we can’t just sit back and take the state’s dishonest word for it that they protecting women’s health.”



Medication abortion restrictions are not the only target of sham laws designed to restrict abortion rights. A number of states have seen the proliferation of unconstitutional pre-viability bans, as well as laws that impose impractical, prohibitive, and medically unwarranted requirements on abortion providers and their practices with the goal of shutting them down.



Not only are these measures deeply disingenuous, they jeopardize women’s health and rights, underscoring the need for federal protections such as Women’s Health Protection Act—proposed legislation that would permanently prohibit states from imposing unconstitutional restrictions on reproductive care providers and block access to safe, legal abortion services.



Donate Now


Related Posts

Complaint: Medical Students for Choice vs. Wright

Abortion,United States, Accountability Bodies,Engaging Policymakers

Testimony of the Center for Reproductive Rights on the Graham-Cassidy-Heller-Johnson Proposal

The Center for Reproductive Rights respectfully submits the following testimony to the U.S. Senate Committee on Finance in strong opposition...

Abortion, Legal Restrictions, Other Barriers, Contraception, Legal Restrictions, Funding for Reproductive Healthcare, Other Financial Barriers, Right to Care, Maternal Health,United States,Engaging Policymakers

June Medical Services v. Gee: Petition for Attorney’s Fees

Abortion, Legal Restrictions,United States,In the Courts, Engaging Policymakers, In the States (USA)

Sign up for email updates.

The most up-to-date news on reproductive rights, delivered straight to you.

Footer Menu

  • Careers
  • Privacy Policy
  • Gift Acceptance Policy
  • Contact Us

Center for Reproductive Rights
© (1992-2024)

Use of this site signifies agreement with our disclaimer and privacy policy.

Better Business Bureau Charity Watch Top Rated Center for Reproductive Rights
This site uses necessary, analytics and social media cookies to improve your experience and deliver targeted advertising. Click "Options" or click here to learn more and customize your cookie settings, otherwise please click "Accept" to proceed.
OPTIONSACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_UA-6619340-11 minuteNo description
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
_parsely_session30 minutesThis cookie is used to track the behavior of a user within the current session.
HotJar: _hjAbsoluteSessionInProgress30 minutesNo description
HotJar: _hjFirstSeen30 minutesNo description
HotJar: _hjid1 yearThis cookie is set by Hotjar. This cookie is set when the customer first lands on a page with the Hotjar script. It is used to persist the random user ID, unique to that site on the browser. This ensures that behavior in subsequent visits to the same site will be attributed to the same user ID.
HotJar: _hjIncludedInPageviewSample2 minutesNo description
HotJar: _hjIncludedInSessionSample2 minutesNo description
HotJar: _hjTLDTestsessionNo description
SSCVER1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for online advertising by creating user profile based on their preferences.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to deliver advertisement when they are on Facebook or a digital platform powered by Facebook advertising after visiting this website.
fr3 monthsThe cookie is set by Facebook to show relevant advertisments to the users and measure and improve the advertisements. The cookie also tracks the behavior of the user across the web on sites that have Facebook pixel or Facebook social plugin.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
IMRID1 year 24 daysThe domain of this cookie is owned by Nielsen. The cookie is used for storing the start and end of the user session for nielsen statistics. It helps in consumer profiling for online advertising.
personalization_id2 yearsThis cookie is set by twitter.com. It is used integrate the sharing features of this social media. It also stores information about how the user uses the website for tracking and targeting.
TDID1 yearThe cookie is set by CloudFare service to store a unique ID to identify a returning users device which then is used for targeted advertising.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
adEdition1 dayNo description
akaas_MSNBC10 daysNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
geoEdition1 dayNo description
next-i18next1 yearNo description
SAVE & ACCEPT
Powered by CookieYes Logo
Scroll Up